arising from J. Yin et al. Nature Communications https://doi.org/10.1038/s41467-022-30601-3 (2022)

Orexin receptors (OX1 receptor and OX2 receptor) are G protein-coupled receptors. A recent study by Yin et al.1 was based on the prior proposal that OX2 receptor would couple much more strongly to Gq than Gi family proteins. The complexes of the agonist-bound OX2 receptor with Gq mimetic or Gi were visualized by cryo-electron microscopy, and the observed differences in the interactions between the receptor and the G proteins were proposed to constitute the structural basis for the weaker coupling to Gi. However, there is no unequivocal support for this preference in the literature and the findings of this study1 may depend on the experimental setup and not reflect physiological G protein coupling of OX2R.

The study of Yin et al. supplied structural information on G protein interaction of the agonist-bound OX2 receptor1. For instance, conformation of both the receptor and the agonist in complex were seen to adapt to different G proteins, in this case a Gq mimetic or Gi. However, the interaction of the chimeric G proteins—as used here for Gq—with the receptors is not necessarily the same as that of native ones2. Yin et al.1 additionally investigated OX2 receptor signaling upon heterologous expression together with Gαq or Gαi1 (for separate assays) in HEK293 cells. They observed inositol phosphate (IP) accumulation but only weak decrease in forskolin-elevated cAMP levels (low maximum response, EC50-values shifted 50–600-fold; Fig 5cd) upon stimulation with the agonists orexin-B and TAK-925. This was taken to indicate preferential activation of Gq, and the structural differences between the receptor interaction with the proteins mimicking Gq and Gi were interpreted in the light of this conclusion.

Orexin receptors are promiscuous receptors. The sum of the studies of their G protein preference is inconclusive due to their limited number, exclusive use of one agonist (orexin-A) and variation between the experimental conditions and assays used. Coupling of the endogenous OX2 receptor in the adrenal cortex and of the mixed receptor population in the hypothalamus to Gi/o, Gs and Gq families of G proteins, as well as coupling of the OX1 receptor-dominant mixed population to Gi/o in the brain stem has been shown using radioactive methods (33P-GTP azidoanilide and 35S-GTPγS labeling)3. In recombinant CHO-K1 cells, the results indicate coupling of both receptors to the putative Gi and Gq responses with largely the same potency4,5,6. In contrast, based on a study with recombinant BIM cells, suggesting that both receptors couple to a pertussis toxin-insensitive Ca2+ elevation while OX2 receptor also couples to a pertussis toxin-sensitive cAMP decrease, it is often inferred that only OX2 receptor couples to Gi7.Interestingly, orexin-A is >1000-fold less potent for the putative Gq than Gi response7. In recombinant HEK293 cells, Gq, Gi and Gs coimmunoprecipitate with OX1 receptor8. Using chimeric G proteins, both receptor subtypes seem to activate all G protein subfamilies except G12/139. The coupling to Gi1,3 and Gq is equipotent (EC50 = 25 and 13 nM, respectively; https://gproteindb.org/signprot/couplings). In yet another study, activated OX2 receptors are shown to couple to all G protein subfamilies except Gs; the EC50 value is 5-fold lower for Gq than Gi/o10 (https://gproteindb.org/signprot/couplings).

The picture thus varies a lot from study to study, and all experimental approaches have their limitations. However, we can confidently state that there is no definitive evidence that the Gi/o-coupling of OX1 and OX2 receptors would be weaker than their Gq-coupling for orexin-A, while other agonists have not been investigated. Yin et al.1 largely miss this literature, which results in a misleading statement: “Several studies of OX2 receptor(…) have indicated that it can also stimulate Gs and Gi signaling, although with reduced orexin potency7,9.” While several studies (but not all) find the Gs-coupling weaker than the Gq-coupling, very few show weaker coupling to Gi than Gq and the cited ones do not; the former suggests much more potent coupling to Gi than Gq while the latter shows an insignificant difference. For orexin-B and TAK 925, Yin et al.1 observed much weaker coupling to cAMP decrease than IP elevation. There are potential explanations to this finding:

  1. (1)

    Multiple factors— including Gαi, Gαs, Gβγ, Ca2+ and phosphorylation— regulate the 9 membrane-bound adenylyl cyclase (AC) isoforms, each in a different way11. The inputs interact negatively or positively, often even synergistically or by gating one another.

  2. (2)

    Orexin receptors can couple to multiple G proteins (and other pathways), which can give rise to several signals to AC: e.g., Gq to Ca2+ or protein kinase C (PKC); Gi to Gαi; Gs to Gαs; in addition, all G proteins could give rise to Gβγ signaling. For OX1 receptor, we could observe Gi-, Gs- and PKC signaling to AC (likely via Gq), and there were differences in OX1R-mediated signaling as compared to other, in principle similar factors4.

  3. (3)

    Cellular cAMP levels are not only regulated by ACs but also by cyclic nucleotide phosphodiesterases (PDEs)12. When AC regulation is investigated, it is necessary to block the PDE activity since (a) it may be difficult to see any cAMP elevation in the presence of efficient PDE activity (e.g., Fig. 9A, in ref. 13) and (b) the receptor under investigation may also regulate PDEs via multiple potential factors11,12.

Due to this high level of complexity, when investigating cAMP signals, one needs to carefully identify all potential players and study these in isolation4. When this is not done, the risk for erroneous conclusions is high. The experimental setup utilized by Yin et al.1 seems to not account for the points above; the AC regulation in this cellular background and the potential orexin receptor-triggered signals were not mapped and no PDE inhibitor was used. This means that the cAMP results1 cannot currently be taken for Gi and that the results reported by Yin et al.1 are not definitive and need to be interpreted carefully.

The proposal that orexin receptors are Gq-coupled largely arises from extrapolation of the original Sakurai et al. paper14 and other papers suggesting strong coupling of the receptors to Ca2+ elevation (and sometimes to phospholipase C (PLC) activation)3,15. While this is not unreasonable, the evidence provided was obtained in recombinant, orexin receptor-overexpressing cells. Very little has been done to assess the molecular details of orexin receptor signaling in CNS neurons, their major target, and most studies do not identify signaling components between the receptors and the “targets” (e.g., ion channels)3,15. There is little direct evidence for Gq coupling in the CNS neurons. Very few studies measure Ca2+ release. A few more directly or indirectly indicate Ca2+ elevation upon orexin receptor activation, but there is nothing pointing at the Gq–PLC axis. It is important to underline that “Ca2+ release” specifically means Ca2+ flux into the cytosol from intracellular stores while “Ca2+ elevation” incorporates both release and influx, the latter of which does not necessarily suggest involvement of Gq. A few studies report an inhibition of the orexin response with PKC inhibitors3. Thus, the statement by Yin et al.1 “These results bolster observations that orexins function mainly by stimulating calcium release through activating Gq3,14” is inaccurate and misleading. We definitely do not take that stand in our review3.

In conclusion, while the Gq signaling seems dominant in many experimental scenarios5,6, we have no proof that this is the case physiologically. Studies such as Yin et al.1 provide valuable information on the structural basis of the receptors’ interactions with G proteins, and similar rigor is needed when the interactions are assessed functionally. Further studies of orexin-B (and synthetic agonists) signaling will contribute to the assessment of potential biased signaling.